首页> 美国卫生研究院文献>Journal of Clinical Medicine >Elevated Levels of Monocyte Chemotactic Protein-1 in the Follicular Fluid Reveals Different Populations among Women with Severe Endometriosis
【2h】

Elevated Levels of Monocyte Chemotactic Protein-1 in the Follicular Fluid Reveals Different Populations among Women with Severe Endometriosis

机译:卵泡液中单核细胞趋化蛋白-1水平升高揭示了严重子宫内膜异位症妇女的不同人群。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To determine if a modification of the cytokine profile occurs in the follicular fluid (FF) of women with endometriosis undergoing in vitro fertilization (IVF), we performed a prospective observational study from January 2018 to February 2019. In total, 87 women undergoing IVF were included: 43 for severe endometriosis-related infertility and 40 controls with other causes of infertility. The cytokine profile of the FF was determined by multiplex fluorescent-bead-based technology allowing the measurement of 59 cytokines. Monocyte Chemoattractant Protein 1 (MCP-1) was the only variable retained in the multivariate analysis. We identified two subgroups of patients in the endometriosis group: MCP-1-low group ( = 23), which had FF MCP-1 levels comparable to the control group, and MCP-1-high ( = 20), which had significantly higher FF levels. Only patients in the MCP-1-high group had a significantly altered cytokine profile in the FF, and had a significantly higher serum estradiol level ( = 0.002) and a significantly lower number of oocytes recovered ( = 0.01) compared to the MCP-1-low and the control group. Our study has shown an alteration of the oocyte microenvironment in women with endometriosis associated with high follicular fluid levels of MCP-1, allowing the identification of a subgroup of endometriosis patients with a potentially worse prognosis.
机译:为了确定接受体外受精(IVF)的子宫内膜异位症妇女的卵泡液(FF)是否发生细胞因子谱的改变,我们从2018年1月至2019年2月进行了一项前瞻性观察研究。总共有87名接受IVF的妇女包括:43例与严重子宫内膜异位症相关的不孕症,40例因其他原因引起的不孕症。 FF的细胞因子概况是通过基于多重荧光珠的技术确定的,可以测量59种细胞因子。单核细胞趋化蛋白1(MCP-1)是多元分析中唯一保留的变量。我们确定了子宫内膜异位症组的两个患者亚组:MCP-1低组(= 23),其FF MCP-1水平与对照组相当; MCP-1高组(= 20),其明显高于对照组。 FF级。与MCP-1相比,只有MCP-1高组的患者FF中的细胞因子谱有显着改变,并且血清雌二醇水平显着较高(= 0.002),回收的卵母细胞数量也显着较低(= 0.01)。 -低和对照组。我们的研究表明,子宫内膜异位症患者的卵母细胞微环境改变与高卵泡液水平的MCP-1相关,从而可以鉴定出子宫内膜异位症患者亚组,其预后可能更差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号